RGA Target Raised to $263 by Piper Sandler, Implying 15.5% Upside
Piper Sandler raised RGA’s price target to $263, implying 15.5% upside as shares have already climbed 10.2%. The insurer highlighted solid Q4 2025 results with growth and innovation initiatives driving its optimistic outlook.
1. Piper Sandler Increases Price Target
On February 6, Piper Sandler bumped RGA’s target to $263, signaling confidence in the reinsurer’s growth trajectory. This new level represents a 15.5% gain from current trading levels, reflecting bullish sentiment on RGA’s risk management and capital solutions.
2. Stock Performance & Market Capitalization
RGA shares have surged 10.2% to approximately $227, with intraday swings between $218.58 and $229.17. The company’s market cap stands near $14.9 billion, underpinned by robust trading volumes and expanding investor interest in its global reinsurance operations.
3. Q4 2025 Earnings Call Highlights
RGA reported strong Q4 results, emphasizing revenue growth, expense discipline and innovation in life and health reinsurance. Executive commentary focused on strategic initiatives to enhance underwriting performance and capital efficiency, laying the groundwork for the projected upside.